ID   Raji 6-TGR
AC   CVCL_Y035
DR   cancercelllines; CVCL_Y035
DR   Wikidata; Q54949146
RX   DOI=10.2177/jsci.11.346;
CC   Population: African; Nigerian.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 17
//
RX   DOI=10.2177/jsci.11.346;
RA   Ikewaki N.;
RT   "Establishment of a 6-thioguanine (6-TG)-neo-resistant mutant human
RT   lymphoma cell line.";
RL   Jpn. J. Clin. Immunol. 11:346-356(1988).
//